News
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...
An Okanagan man is suing Interior Health and several doctors for malpractice after a cancer misdiagnosis delayed care and ...
The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results